Cancer stem cells with positive CD44 marker in advanced malignant epithelial ovarian tumors, and their relation with chemotherapeutic sensitivity
Conclusion: Overexpression of CD44 in epithelial ovarian cancer is a strong risk factor for resistance to conventional chemotherapy.
Source: Journal of Evidence-Based Women’s Health Journal Society - Category: OBGYN Tags: Original articles Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Epithelial Cancer | Health | OBGYN | Ovarian Cancer | Ovaries | Stem Cell Therapy | Stem Cells | Study | Women